Stock listing
Munich:9W9 Cellebrite DI Ltd. Aktie
German listing (Munich) of Cellebrite DI Ltd. · home listing NASDAQ:CLBT
Follow Cellebrite DI Ltd. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CLBT
$10.77 USD -0.39 (-3.5%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CLBT
- Day range
- $10.72 – $11.41 USDNov 20, 2026
- Volume
- 2.71M sharesNov 20, 2026
- Market cap
- $2.71B USDAt the close on Nov 20, 2026 · price × 251.3M shares outstanding
- 52-week range
- $9.58 – $19.39 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $27.67M USDMedian day 2.21M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CLBT · Home | $10.77 USD | -0.39 (-3.5%) | 2,709,368 | $11.18 | $11.41 | $10.72 | $11.16 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CLBT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.77 | -0.39 | -3.5% | $11.18 | $11.41 | $10.72 | 2,709,368 | |
| $11.16 | +0.51 | +4.8% | $10.65 | $11.30 | $10.56 | 2,355,703 | |
| $10.65 | -0.47 | -4.2% | $11.04 | $11.07 | $10.43 | 3,477,902 | |
| $11.12 | -0.41 | -3.6% | $11.42 | $11.87 | $11.07 | 2,738,873 | |
| $11.53 | +0.64 | +5.9% | $11.00 | $11.85 | $10.89 | 5,109,352 | |
| $10.89 | -1.81 | -14.3% | $13.37 | $13.65 | $10.88 | 6,493,473 | |
| $12.70 | +0.06 | +0.5% | $12.60 | $12.89 | $12.58 | 3,035,734 | |
| $12.64 | -0.06 | -0.5% | $12.60 | $12.87 | $12.41 | 3,071,705 | |
| $12.70 | +0.25 | +2.0% | $12.47 | $12.84 | $12.45 | 1,676,524 | |
| $12.45 | +0.07 | +0.6% | $12.34 | $12.51 | $12.18 | 1,605,311 | |
| $12.38 | -0.05 | -0.4% | $12.36 | $12.61 | $12.13 | 2,301,795 | |
| $12.43 | +0.18 | +1.5% | $12.27 | $12.61 | $12.27 | 1,811,588 | |
| $12.25 | +0.12 | +1.0% | $12.00 | $12.29 | $11.82 | 1,400,422 | |
| $12.13 | -0.02 | -0.2% | $12.11 | $12.34 | $12.08 | 1,587,823 | |
| $12.15 | -0.13 | -1.1% | $12.24 | $12.27 | $12.02 | 1,741,417 | |
| $12.28 | +0.36 | +3.0% | $11.68 | $12.31 | $11.49 | 2,114,917 | |
| $11.92 | -0.01 | -0.1% | $11.84 | $12.12 | $11.78 | 917,911 | |
| $11.93 | -0.30 | -2.5% | $12.13 | $12.18 | $11.85 | 1,175,476 | |
| $12.23 | +0.13 | +1.1% | $12.14 | $12.24 | $12.00 | 986,440 | |
| $12.10 | +0.31 | +2.6% | $11.70 | $12.18 | $11.68 | 1,393,636 | |
| $11.79 | +0.29 | +2.5% | $11.55 | $11.79 | $11.43 | 1,427,888 | |
| $11.50 | +0.13 | +1.1% | $11.40 | $11.57 | $11.37 | 885,728 | |
| $11.37 | +0.225 | +2.0% | $11.24 | $11.43 | $11.13 | 1,272,999 | |
| $11.15 | +0.115 | +1.0% | $10.82 | $11.22 | $10.82 | 1,043,057 | |
| $11.03 | -0.35 | -3.1% | $11.45 | $11.48 | $10.85 | 1,532,200 | |
| $11.38 | +0.55 | +5.1% | $10.68 | $11.43 | $10.68 | 2,615,400 | |
| $10.83 | -0.55 | -4.8% | $11.33 | $11.43 | $10.68 | 1,966,700 | |
| $11.38 | -0.06 | -0.5% | $11.47 | $11.61 | $11.38 | 2,207,300 | |
| $11.44 | +0.18 | +1.6% | $11.30 | $11.54 | $11.27 | 1,604,900 | |
| $11.26 | -0.08 | -0.7% | $11.46 | $11.49 | $11.23 | 1,398,500 | |
| $11.34 | +0.115 | +1.0% | $11.34 | $11.38 | $11.16 | 1,056,900 | |
| $11.23 | -0.145 | -1.3% | $11.30 | $11.41 | $11.09 | 1,852,800 | |
| $11.37 | +0.17 | +1.5% | $11.32 | $11.44 | $11.21 | 1,392,400 | |
| $11.20 | +0.13 | +1.2% | $11.10 | $11.34 | $10.97 | 3,110,900 | |
| $11.07 | -0.07 | -0.6% | $11.14 | $11.22 | $10.97 | 2,046,000 | |
| $11.14 | -0.12 | -1.1% | $11.34 | $11.40 | $11.03 | 1,844,500 | |
| $11.26 | +0.33 | +3.0% | $10.92 | $11.32 | $10.82 | 3,113,900 | |
| $10.93 | -0.14 | -1.3% | $11.00 | $11.01 | $10.80 | 3,514,800 | |
| $11.07 | +0.28 | +2.6% | $10.67 | $11.10 | $10.48 | 2,879,000 | |
| $10.79 | -0.58 | -5.1% | $11.34 | $11.34 | $10.70 | 3,427,400 | |
| $11.37 | -0.13 | -1.1% | $11.43 | $11.54 | $11.29 | 1,254,000 | |
| $11.50 | -0.16 | -1.4% | $11.71 | $11.88 | $11.47 | 3,443,700 | |
| $11.66 | +0.10 | +0.9% | $11.75 | $11.78 | $11.41 | 3,617,800 | |
| $11.56 | -0.06 | -0.5% | $11.62 | $11.66 | $11.32 | 4,421,200 | |
| $11.62 | -0.20 | -1.7% | $11.82 | $11.82 | $11.50 | 1,610,300 | |
| $11.82 | +0.39 | +3.4% | $11.43 | $11.83 | $11.34 | 1,840,500 | |
| $11.43 | +0.18 | +1.6% | $11.12 | $11.57 | $11.12 | 2,464,400 | |
| $11.25 | -0.42 | -3.6% | $11.41 | $11.56 | $11.23 | 4,551,400 | |
| $11.67 | +0.44 | +3.9% | $11.27 | $11.85 | $11.25 | 3,543,900 | |
| $11.23 | -0.095 | -0.8% | $11.42 | $11.50 | $11.05 | 2,366,800 | |
| $11.33 | -0.105 | -0.9% | $11.25 | $11.46 | $11.07 | 2,399,100 | |
| $11.43 | -0.02 | -0.2% | $11.42 | $11.56 | $11.25 | 2,627,100 | |
| $11.45 | 0.00 | 0.0% | $11.33 | $11.53 | $11.15 | 3,783,400 | |
| $11.45 | -0.49 | -4.1% | $11.94 | $11.94 | $11.43 | 3,298,200 | |
| $11.94 | +0.32 | +2.8% | $11.84 | $11.99 | $11.65 | 1,361,700 | |
| $11.62 | -0.23 | -1.9% | $11.86 | $11.97 | $11.40 | 2,125,400 | |
| $11.85 | -0.15 | -1.3% | $11.88 | $11.98 | $11.81 | 1,772,200 | |
| $12.00 | +0.01 | +0.1% | $11.80 | $12.13 | $11.80 | 1,330,200 | |
| $11.99 | -0.30 | -2.4% | $12.28 | $12.43 | $11.93 | 1,537,800 | |
| $12.29 | +0.67 | +5.8% | $11.90 | $12.36 | $11.90 | 2,943,200 | |
| $11.62 | +0.33 | +2.9% | $11.13 | $11.66 | $11.06 | 2,368,900 | |
| $11.29 | -0.20 | -1.7% | $11.40 | $11.56 | $11.21 | 2,597,900 | |
| $11.49 | +0.44 | +4.0% | $11.06 | $11.78 | $11.01 | 3,463,700 | |
| $11.05 | -0.26 | -2.3% | $11.30 | $11.40 | $11.01 | 3,812,500 | |
| $11.31 | +0.07 | +0.6% | $11.20 | $11.44 | $10.97 | 4,006,800 |
- Ticker
- Munich:9W9
- Asset type
- Stock
- Sector
- Technology
- Industry
- Software
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
CLBT FY26 Q3 Historical Financial Tables and Supplemental Data
Latest earnings call · Nov 12, 2026
Cellebrite DI (NASDAQ:CLBT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 13, 2026
Q2 2026 Earnings Presentation
Earnings · 46 slides
Latest news
CLBT FY26 Q3 Historical Financial Tables and Supplemental Data
Nov 12, 2026
Closed $10.89 (-14.3%) on Nov 12, 2026
Cellebrite Reports Third-Quarter 2026 Results
Nov 12, 2026
Closed $10.89 (-14.3%) on Nov 12, 2026
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
Nov 9, 2026
Closed $12.70 (+2.0%) on Nov 9, 2026
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
Nov 5, 2026
Closed $12.38 (-0.4%) on Nov 5, 2026
Genesis Momentum Powers Cellebrite's Autumn Release: More Evidence, Deeper Insight, Broader Access for Investigations
Oct 21, 2026
Closed $11.50 (+1.1%) on Oct 21, 2026
Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe
Sep 23, 2026
Closed $11.50 (-1.4%) on Sep 23, 2026
Cellebrite เปิดรับการเสนอชื่อเข้าชิง JUSTYS ประจำปี 2570 งานประกาศรางวัลชั้นนำเชิดชูฮีโร่ผู้ปิดทองหลังพระที่ทำให้โลกปลอดภัย
Sep 23, 2026
Closed $11.50 (-1.4%) on Sep 23, 2026
Cellebrite ขยายชุมชนดิจิทัลระดับโลก 'The 101' สำหรับผู้เชี่ยวชาญด้านนิติวิทยาศาสตร์ดิจิทัลและงานสืบสวน
Sep 17, 2026
Closed $11.82 (+3.4%) on Sep 17, 2026
Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals
Sep 17, 2026
Closed $11.82 (+3.4%) on Sep 17, 2026
Chris Wade ซีทีโอของ Cellebrite กุมทัพ Cellebrite Labs เร่งยกระดับการวิจัยเทคโนโลยีมือถือ
Sep 14, 2026
Closed $11.67 (+3.9%) on Sep 14, 2026
Cellebrite DI Ltd. on 6ix
- Sector
- Technology
- Industry
- Software
- News releases
- 54 in the last 12 months · 183 in all · newest Nov 12, 2026 · oldest 2021
- Calls
- 21 calls with a replay · 21 with a transcript · latest Nov 12, 2026
- Decks
- 25 decks · latest Aug 13, 2026
Where Cellebrite DI Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CLBT · Home listing | NASDAQ | United States | USD |
| gettex:9W9 | gettex | Germany | EUR |
| LS Exchange:A3D00S | LS Exchange | Germany | EUR |
| BOATS:CLBT | BOATS | United States | USD |
| Lang & Schwarz:A3D00S | Lang & Schwarz | Germany | EUR |
| Tradegate:9W9 | Tradegate | Germany | EUR |
| Dusseldorf:9W9 | Dusseldorf | Germany | EUR |
| Frankfurt:9W9 | Frankfurt | Germany | EUR |
| Munich:9W9 · This page | Munich | Germany | EUR |
| Stuttgart:9W9 | Stuttgart | Germany | EUR |
Valuation
P/E 41.5× against a median of 27.3×: 6th lowest of 8 Software companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.25B USD
- P/E
- 41.5×
- EV/sales
- 4.2×
- EV/EBITDA
- 24.0×
- Price/book
- 4.7×
- Gross margin
- 82.3%
- Operating margin
- 12.0%
- Net margin
- 12.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.54
Software: the 10 companies nearest in size, of 632 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cellebrite DI Ltd. · NASDAQ:CLBT | US$2.71B | US$2.25B | 41.5× | 4.2× | 24.0× | 4.7× | 12.1% | 0.0× | 0.54 |
| Alarm.com Holdings, Inc. · NASDAQ:ALRM | US$3.19B | US$3.22B | 27.3× | 3.0× | 18.1× | 3.6× | 10.8% | 0.6× | 0.39 |
| Klaviyo, Inc. Series A · NYSE:KVYO | US$3.13B | US$2.56B | 396× | 1.8× | 210× | 3.6× | 0.5% | 0.2× | 0.46 |
| Agilysys, Inc. · NASDAQ:AGYS | US$3.12B | US$2.98B | 70.3× | 8.7× | 56.3× | 8.7× | 12.9% | 0.0× | 0.55 |
| monday.com Ltd. · NASDAQ:MNDY | US$3.05B | US$2.14B | 21.3× | 1.5× | 21.6× | 4.4× | 10.1% | 0.3× | 0.50 |
| Totvs S.A. · BMFBOVESPA:TOTS3 | US$2.96B | US$3.53B | 12.3× | 3.0× | 11.2× | 3.3× | 20.7% | 0.9× | n/a |
| Freshworks Inc. · NASDAQ:FRSH | US$2.90B | US$2.24B | 13.9× | 2.4× | 22.1× | 3.2× | 22.3% | 0.0× | 0.55 |
| Beijing Shiji Information Technology Co., Ltd. Class A · SZSE:002153 | US$2.59B | US$2.14B | n/a | 5.2× | n/a | 2.6× | −6.2% | 0.0× | n/a |
| Wix.com Ltd. · NASDAQ:WIX | US$2.47B | US$3.46B | n/a | 1.6× | n/a | n/a | −8.5% | n/a | 0.64 |
| Primarius Technologies Co. Ltd. Class A · SSE:688206 | US$2.38B | US$2.14B | n/a | 24.3× | n/a | 3.9× | −1.2% | 0.0× | n/a |
| Intsig Information Co., Ltd. Class A · SSE:688615 | US$2.37B | US$1.86B | 31.1× | 5.9× | n/a | 5.0× | 24.3% | 0.0× | n/a |
| Median of the others | US$2.93B | US$2.40B | 27.3× | 3.0× | 21.8× | 3.6× | 10.4% | 0.0× | 0.53 |
Forecasts
6 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 15.21 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.58 · 8 analysts
- Revenue, year to Dec 2026
- 555.5M · 8 analysts
Team and board
| Officer | Role |
|---|---|
| Shiven Ramji | Chief Executive Officer |
| David Barter | Chief Financial Officer |
| Holly Windham | General Counsel & Chief Compliance Officer |
| Andrew Kramer | Investor Relations |
| Victor Cooper | Sr. Director of Corporate Communications |
| Victor CooperSr | Director of Corporate Communications and Content |
| Rogerio Rizzi | executive vice president of Corporate Strategy and Development |
| Chris Wade | Chief Technology Officer |
| David Gee | Chief Marketing Officer |
| Jordan McQuown | Chief Information Officer and Chief Information Security Officer |
| Marcus Jewell | Global Chief Revenue Officer |
| Sigalit Shavit | Chief Information Officer |
| Zohar Tadmor | Chief People Officer |
Events
Calls
| Call | When | Status |
|---|---|---|
| Cellebrite DI (NASDAQ:CLBT) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 8:30 PM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q1 2026 Earnings Call | Thu, May 14, 2026 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q4 2025 Earnings Call | Wed, Feb 11, 2026 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q3 2025 Earnings Call | Wed, Nov 12, 2025 · 5:00 PM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q2 2025 Earnings Call | Thu, Aug 14, 2025 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q1 2025 Earnings Call | Wed, May 14, 2025 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q4 2024 Earnings Call | Thu, Feb 13, 2025 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q3 2024 Earnings Call | Wed, Nov 06, 2024 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q2 2024 Earnings Call | Thu, Aug 15, 2024 · 8:30 AM ET | Replay |
All 21 calls
| Call | When | Status |
|---|---|---|
| Cellebrite DI (NASDAQ:CLBT) Q1 2024 Earnings Call | Thu, May 23, 2024 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q4 2023 Earnings Call | Thu, Feb 15, 2024 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q3 2023 Earnings Call | Tue, Nov 14, 2023 · 9:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q2 2023 Earnings Call | Tue, Aug 08, 2023 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q1 2023 Earnings Call | Wed, May 10, 2023 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q4 2022 Earnings Call | Wed, Feb 15, 2023 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q3 2022 Earnings Call | Thu, Nov 17, 2022 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q2 2022 Earnings Call | Thu, Aug 11, 2022 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q1 2022 Earnings Call | Thu, May 12, 2022 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q4 2021 Earnings Call | Wed, Feb 16, 2022 · 8:30 AM ET | Replay |
| Cellebrite DI (NASDAQ:CLBT) Q3 2021 Earnings Call | Wed, Nov 10, 2021 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 · Before open | −14.3% |
| Q2 2026 | Aug 13, 2026 · Before open | −29.2% |
| Q1 2026 | May 14, 2026 · Before open | +8.4% |
| Q4 2025 | Feb 11, 2026 · Before open | −4.5% |
| Q3 2025 | Nov 12, 2025 · After close | +20.7% |
| Q2 2025 | Aug 14, 2025 · Before open | +9.3% |
| Q1 2025 | May 14, 2025 · Before open | −11.5% |
| Q4 2024 | Feb 13, 2025 · Before open | −12.9% |
| Q3 2024 | Nov 6, 2024 · Before open | −0.3% |
| Q2 2024 | Aug 15, 2024 · Before open | +7.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 23, 2024 · Before open | +2.3% |
| Q4 2023 | Feb 15, 2024 · Before open | +10.9% |
| Q3 2023 | Nov 14, 2023 · Before open | +5.6% |
| Q2 2023 | Aug 8, 2023 · Before open | +9.0% |
| Q1 2023 | May 10, 2023 · Before open | −3.3% |
| Q4 2022 | Feb 15, 2023 · Before open | +13.9% |
| Q3 2022 | Nov 17, 2022 · Before open | −1.2% |
| Q2 2022 | Aug 11, 2022 · Before open | −6.9% |
| Q1 2022 | May 12, 2022 · Before open | −1.7% |
| Q4 2021 | Feb 16, 2022 · Before open | +10.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 46 slides | Aug 13, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 46 slides | May 14, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 39 slides | Feb 11, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 41 slides | Nov 12, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 41 slides | Aug 14, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 21 slides | May 14, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 23 slides | Feb 13, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 26 slides | Nov 6, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 22 slides | Aug 15, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 22 slides | May 23, 2024 |
All 25 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2023 Earnings Presentation | Earnings | 22 slides | Feb 15, 2024 |
| Q3 2023 Earnings Presentation | Earnings | 22 slides | Nov 14, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 22 slides | Aug 8, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 23 slides | May 10, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 21 slides | Nov 17, 2022 |
| Q4 2021 Earnings Presentation | Earnings | 24 slides | Feb 16, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 23 slides | Nov 10, 2021 |
| SPAC Merger (August 2021) | SPAC merger | 54 slides | Aug 13, 2021 |
| Cellebrite — SPAC Merger (August 2021) | SPAC merger | 28 slides | Aug 12, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 28 slides | August 2021 |
| Cellebrite — SPAC Merger (June 2021) | SPAC merger | 56 slides | Jun 11, 2021 |
| SPAC Merger (June 2021) | SPAC merger | 55 slides | June 2021 |
| SPAC Merger (April 2021) | SPAC merger | 50 slides | Apr 9, 2021 |
| Cellebrite — SPAC Merger (April 2021) | SPAC merger | 11 slides | Apr 9, 2021 |
| Cellebrite — Technical Presentation (May 2020) | Technical | 33 slides | May 26, 2020 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 475.7M | 401.2M | 325.1M | 270.7M | 246.2M | 194.9M | 171.9M |
| Cost of revenue | 75.2M | 62.6M | 53.2M | 50.7M | 42.6M | 37.9M | 35.8M |
| Gross profit | 400.5M | 338.6M | 271.9M | 219.9M | 203.7M | 157.0M | 136.0M |
| Research and development | 113.9M | 98.4M | 84.4M | 80.6M | 65.5M | 54.4M | 46.6M |
| Selling, general and administrative | 65.3M | 50.9M | 43.4M | 40.9M | 47.9M | 29.9M | 28.6M |
| Operating income | 66.5M | 56.9M | 33.2M | 1.04M | 13.8M | 9.22M | -1.52M |
| Depreciation and amortization | 11.9M | 10.6M | 10.0M | 9.19M | 7.01M | 5.88M | 4.08M |
| EBITDA | 78.3M | 67.5M | 43.2M | 10.2M | 20.8M | 15.1M | 2.56M |
| Interest expense | 523.0K | 349.8M | 141.0K | 149.0K | 153.0K | 1.42M | 352.0K |
| Income before tax | 90.7M | -276.0M | -75.6M | 120.8M | 82.3M | 11.4M | 1.42M |
| Income tax | 12.4M | 7.02M | 5.54M | -45.0K | 10.9M | 5.62M | 3.29M |
| Net income | 78.3M | -283.0M | -81.1M | 120.8M | 71.4M | 5.78M | -1.88M |
| Earnings per share, basic | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 | -0.08 | -0.08 |
| Earnings per share, diluted | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 | -0.08 | -0.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 124.5M | 191.7M | 189.5M | 87.6M | 146.0M | 128.7M | 81.7M |
| Short-term investments | 151.5M | 101.8M | 38.7M | 44.6M | 0 | 108.9M | 123.7M |
| Receivables | 105.0M | 82.4M | 77.3M | 78.8M | 67.5M | 66.3M | 44.2M |
| Inventory | 7.60M | 8.94M | 9.94M | 10.2M | 6.51M | 4.75M | 3.96M |
| Current assets | 575.9M | 567.6M | 422.1M | 295.9M | 273.2M | 324.3M | 261.9M |
| Property, plant and equipment | 22.2M | 17.0M | 15.9M | 17.3M | 16.8M | 16.1M | 14.8M |
| Goodwill | 119.6M | 28.7M | 26.8M | 26.8M | 26.8M | 9.46M | 0 |
| Total assets | 938.9M | 690.6M | 532.9M | 403.3M | 339.8M | 364.4M | 280.2M |
| Accounts payable | 16.8M | 11.1M | 8.28M | 4.61M | 9.55M | 4.73M | 5.36M |
| Current liabilities | 369.7M | 295.5M | 253.8M | 207.8M | 186.6M | 159.4M | 99.2M |
| Total debt | 22.7M | 11.0M | 14.1M | 15.4M | |||
| Total liabilities | 454.5M | 354.5M | 498.7M | 329.4M | 413.1M | 199.4M | 221.4M |
| Shareholders' equity | 484.3M | 336.0M | 34.2M | 73.9M | -73.3M | 63.8M | 58.8M |
| Shares outstanding | 248.6M | 234.5M | 203.2M | 193.0M | 187.7M | 124.7M | 194.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 173.5M | 132.2M | 102.1M | 20.6M | 36.1M | 66.5M | 16.1M |
| Capital spending | -13.2M | -8.57M | -5.23M | -6.90M | -5.11M | -6.18M | -6.21M |
| Free cash flow | 160.3M | 123.6M | 96.8M | 13.7M | 30.9M | 60.3M | 9.92M |
| Cash from investing | -268.3M | -149.5M | -22.5M | -91.2M | 45.2M | -6.45M | -46.7M |
| Cash from financing | 25.1M | 20.7M | 21.8M | 14.0M | -68.4M | -8.59M | 75.5M |
| Dividends paid | 0 | 0 | -100.0M | -10.0M | -25.0M | ||
| Share buybacks | -11.0K | 0 | 0 | -85.0K | -808.0K | ||
| Change in cash | -69.7M | 3.35M | 101.3M | -56.7M | 12.9M | 51.5M | 44.9M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Nov 16, 2026 | Current report | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Nov 12, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 10, 2026 | Other filings | SEC |
Show 200 filings
This page holds 200 of 370 filings. Open Filings
Cap table
Built by 6ix from Cellebrite DI Ltd.’s releases
- Common shares
- 251,341,060
- Fully diluted
- 251,341,060
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 251,341,060 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 251,341,060 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Brandon Van Buren Other companies: Bilander Acquisition Corp (Director · Jul 15, 2021 – Jul 15, 2021 · Past); Nebula Caravel Acquisition Corp (Director · Dec 8, 2020 – Dec 8, 2020 · Past); Zix Corporation (Director · Feb 20, 2019 – Feb 20, 2019 · Past) | Director · Since at least Mar 18, 2026 |
| David Barter Other companies: New Relic Inc (CHIEF FINANCIAL OFFICER · Aug 17, 2022 – Nov 8, 2023 · Past); C3.ai, Inc. (Senior VP and CFO · Dec 8, 2020 – Nov 12, 2021 · Past); Model N Inc (SVP, Chief Financial Officer · Nov 30, 2018 – Aug 14, 2020 · Past) | Chief Financial Officer · Since at least Mar 18, 2026 |
| Michael D Capellas Other companies: Cisco Systems, Inc. (Director · Since at least Dec 6, 2023); SkinHealth Systems Inc. (Director · Jul 8, 2024 – Jul 8, 2024 · Past); Flex Ltd. (Director · May 28, 2024 – May 28, 2024 · Past) | Director · Since at least Mar 18, 2026 |
| Dafna Gruber Other companies: Check Point Software Technologies Ltd. (Director · Since at least Mar 18, 2026); ICL Group Ltd. (Member of the Board · Since at least Mar 18, 2026) | Director · Since at least Mar 18, 2026 |
| Adam Clammer Other companies: Nebula Caravel Acquisition Corp (Director · Feb 27, 2024 – Feb 27, 2024 · Past) | Director · Since at least Mar 18, 2026 |
| Andrew Kramer Other companies: Okta, Inc. (Investor Relations · Apr 30, 2026 – Nov 5, 2026 · Past) | Investor Relations · Since at least Sep 2, 2026 |
| David Gee Other companies: Infoblox Inc (Executive VP, Marketing · Apr 19, 2012 – Sep 21, 2015 · Past) | Chief Marketing Officer · Since at least Mar 18, 2026 |
| Marcus Jewell Other companies: Juniper Networks Inc (EVP Chief Revenue Officer · Aug 12, 2021 – Mar 18, 2022 · Past) | Global Chief Revenue Officer · Since at least Mar 18, 2026 |
| Shiven Ramji Other companies: Okta, Inc. (President of Products and Technology · Apr 30, 2026 – Nov 5, 2026 · Past) | Chief Executive Officer, Director · Since at least Apr 30, 2026 |
| Troy K. Richardson Other companies: Unisys Corporation New (Director · Since at least Jun 3, 2026) | Director · Since at least Sep 17, 2026 |
All 23 people
| Person | Seat |
|---|---|
| Chris Wade | Chief Technology Officer · Since at least Mar 18, 2026 |
| Holly Windham | GC & Chief Compliance Officer · Since at least Nov 12, 2025 |
| Jordan McQuown | Chief Information Officer and Chief Information Security Officer · Since at least Nov 5, 2026 |
| Nadine Baudot-Trajtenberg | Director · Since at least Sep 17, 2026 |
| Rogerio Rizzi | executive vice president of Corporate Strategy and Development · Since Nov 5, 2026 |
| Ronnen Armon | See Remarks · Since at least Mar 18, 2026 |
| Ryusuke Utsumi | Director · Since at least Mar 18, 2026 |
| Sigalit Shavit | Chief Information Officer · Since at least Mar 18, 2026 |
| Thomas E Hogan | Chief Executive Officer, Director · Since at least Mar 18, 2026 |
| Victor Cooper | Sr. Director of Corporate Communications · Since at least May 6, 2026 |
| Victor CooperSr | Director of Corporate Communications and Content · Since at least Dec 2, 2025 |
| Yonatan Domnitz | Director · Since at least Mar 18, 2026 |
| Zohar Tadmor | Chief People Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Cellebrite DI Ltd.